338 related articles for article (PubMed ID: 17116742)
21. Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice.
Schwedler SB; Amann K; Wernicke K; Krebs A; Nauck M; Wanner C; Potempa LA; Galle J
Circulation; 2005 Aug; 112(7):1016-23. PubMed ID: 16087790
[TBL] [Abstract][Full Text] [Related]
22. Conversion of native oligomeric to a modified monomeric form of human C-reactive protein.
Kresl JJ; Potempa LA; Anderson BE
Int J Biochem Cell Biol; 1998 Dec; 30(12):1415-26. PubMed ID: 9924810
[TBL] [Abstract][Full Text] [Related]
23. Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.
Ullah N; Wu Y
Cell Biochem Biophys; 2022 Dec; 80(4):595-608. PubMed ID: 35997934
[TBL] [Abstract][Full Text] [Related]
24. Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils.
Khreiss T; József L; Potempa LA; Filep JG
Circ Res; 2005 Sep; 97(7):690-7. PubMed ID: 16123332
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of megakaryocytopoiesis in mice by human modified C-reactive protein (mCRP).
Potempa LA; Motie M; Wright KE; Crump BL; Radosevich JA; Sakai N; Lai G; Tanaka K; Kojima E; Tsuboi A
Exp Hematol; 1996 Feb; 24(2):258-64. PubMed ID: 8641350
[TBL] [Abstract][Full Text] [Related]
26. Acidic pH promotes oxidation-induced dissociation of C-reactive protein.
Li SL; Feng JR; Zhou HH; Zhang CM; Lv GB; Tan YB; Ge ZB; Wang MY
Mol Immunol; 2018 Dec; 104():47-53. PubMed ID: 30408622
[TBL] [Abstract][Full Text] [Related]
27. C-Reactive Protein and Cancer: Interpreting the Differential Bioactivities of Its Pentameric and Monomeric, Modified Isoforms.
Potempa LA; Rajab IM; Olson ME; Hart PC
Front Immunol; 2021; 12():744129. PubMed ID: 34552600
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein: how conformational changes influence inflammatory properties.
Eisenhardt SU; Thiele JR; Bannasch H; Stark GB; Peter K
Cell Cycle; 2009 Dec; 8(23):3885-92. PubMed ID: 19887916
[TBL] [Abstract][Full Text] [Related]
29. A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury.
Thiele JR; Zeller J; Kiefer J; Braig D; Kreuzaler S; Lenz Y; Potempa LA; Grahammer F; Huber TB; Huber-Lang M; Bannasch H; Stark GB; Peter K; Eisenhardt SU
Front Immunol; 2018; 9():675. PubMed ID: 29713320
[TBL] [Abstract][Full Text] [Related]
30. Regulation of C-reactive protein conformation in inflammation.
Yao Z; Zhang Y; Wu H
Inflamm Res; 2019 Oct; 68(10):815-823. PubMed ID: 31312858
[TBL] [Abstract][Full Text] [Related]
31. The binding of monomeric C-reactive protein (mCRP) to Integrins αvβ3 and α4β1 is related to its pro-inflammatory action.
Fujita M; Takada YK; Izumiya Y; Takada Y
PLoS One; 2014; 9(4):e93738. PubMed ID: 24695572
[TBL] [Abstract][Full Text] [Related]
32. Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP.
Karlsson J; Wetterö J; Potempa LA; Fernandez-Botran R; O'Neill Y; Wirestam L; Mobarrez F; Sjöwall C
J Autoimmun; 2023 Sep; 139():103073. PubMed ID: 37356347
[TBL] [Abstract][Full Text] [Related]
33. Fueling the flames of colon cancer - does CRP play a direct pro-inflammatory role?
Køstner AH; Fuglestad AJ; Georgsen JB; Nielsen PS; Christensen KB; Zibrandtsen H; Parner ET; Rajab IM; Potempa LA; Steiniche T; Kersten C
Front Immunol; 2023; 14():1170443. PubMed ID: 37006231
[TBL] [Abstract][Full Text] [Related]
34. Monomeric C-reactive protein alters fibrin clot properties on endothelial cells.
Li R; Ren M; Luo M; Chen N; Zhang Z; Luo B; Wu J
Thromb Res; 2012 May; 129(5):e251-6. PubMed ID: 22475312
[TBL] [Abstract][Full Text] [Related]
35. C-reactive protein enhances activation of coagulation system and inflammatory response through dissociating into monomeric form in antineutrophil cytoplasmic antibody-associated vasculitis.
Xu PC; Lin S; Yang XW; Gu DM; Yan TK; Wei L; Wang BL
BMC Immunol; 2015 Mar; 16():10. PubMed ID: 25879749
[TBL] [Abstract][Full Text] [Related]
36. Plasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery Disease.
Crawford JR; Trial J; Nambi V; Hoogeveen RC; Taffet GE; Entman ML
J Cardiovasc Transl Res; 2016 Jun; 9(3):184-193. PubMed ID: 26891844
[TBL] [Abstract][Full Text] [Related]
37. Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities.
Potempa LA; Qiu WQ; Stefanski A; Rajab IM
Front Cardiovasc Med; 2022; 9():979461. PubMed ID: 36158829
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical staining reveals C-reactive protein existing predominantly as altered conformation forms in inflammatory lesions.
Shi P; Li XX; Zhu W; Yang H; Dong C; Li XM
Acta Biol Hung; 2014 Sep; 65(3):265-73. PubMed ID: 25194730
[TBL] [Abstract][Full Text] [Related]
39. Pentameric CRP attenuates inflammatory effects of mmLDL by inhibiting mmLDL--monocyte interactions.
Eisenhardt SU; Starke J; Thiele JR; Murphy A; Björn Stark G; Bassler N; Sviridov D; Winkler K; Peter K
Atherosclerosis; 2012 Oct; 224(2):384-93. PubMed ID: 22901456
[TBL] [Abstract][Full Text] [Related]
40. Immunodetection of pentamer and modified C-reactive protein using surface plasmon resonance biosensing.
Hu WP; Hsu HY; Chiou A; Tseng KY; Lin HY; Chang GL; Chen SJ
Biosens Bioelectron; 2006 Feb; 21(8):1631-7. PubMed ID: 16343891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
